AtriCure, Inc. (ATRC)
32.58
+0.20
(+0.62%)
USD |
NASDAQ |
Feb 20, 16:00
32.63
+0.05
(+0.15%)
After-Hours: 20:00
AtriCure Research and Development Expense (Quarterly) : 22.74M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 352.90M |
| Insulet Corp. | 90.90M |
| Alphatec Holdings, Inc. | 18.68M |
| Boston Scientific Corp. | 569.00M |
| STRATA Skin Sciences, Inc. | 0.172M |